Skip to content

AI-Enhanced Doctor-Patient Communication: Development and Evaluation of Behavior Science-Informed LLM Capability Augmentation Technologies

AI-Enhanced Doctor-Patient Communication: Development and Evaluation of Behavior Science-Informed LLM Capability Augmentation Technologies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122554
Enrollment
Unknown
Registered
2026-04-15
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, type 2 diabetes, chronic obstructive pulmonary disease (COPD), and other common chronic non-communicable diseases (NCDs) in the community.

Interventions

Intervention Group:Physicians in the intervention group will utilize an LLM-assisted communication system based on behavioral science theory, in addition to routine outpatient diagnosis and treatment.
Usual Care Control Group:Physicians communicated with patients according to routine practice, without AI assistance.
Active Comparator:Physicians in this group utilize communication suggestions generated by a general Large Language Model (LLM) as an auxiliary tool during outpatient consultations. The front-end inter

Sponsors

Tsinghua University, Shenzhen Longhua District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Physicians: (1) Hold a practicing (assistant) physician qualification; (2) Have worked in the selected community health service center for at least one year; (3) Work responsibilities involve chronic disease management, including but not limited to hypertension, diabetes, etc.; (4) Agree to participate in the study and sign the informed consent form. 2.Patients: (1) Aged 18 years or older; (2) Clinically diagnosed with at least one chronic non-communicable disease (specifically limited to essential hypertension and type 2 diabetes mellitus); (3) Currently a registered patient at the selected Community Health Center (CHC), or a permanent resident who has received regular follow-up and pharmacotherapy at the center for no less than one year; (4) A permanent resident of study site city during the study period, with no plans for long-term travel outside the city (e.g., returning to hometown, tourism) in the upcoming 3 months.(5) The participant or their accompanying family member possesses proficient Mandarin listening and speaking skills, enabling them to cooperate with the physician for face-to-face interviews and questionnaire surveys. (6) Fully understands the study content, participates voluntarily, and signs the written Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1.Physicians:(1) Clinical practice does not involve the management of non-communicable diseases;(2) Have serious physical illnesses or communication impairments;(3) Are unwilling to participate in the study or refuse to sign the informed consent form. 2.Patients:(1) Currently in the acute complication phase of conditions such as hypertensive crisis or diabetic ketoacidosis, or suffering from other severe physical illnesses requiring urgent hospitalization;(2) Currently participating in other related clinical trials or health management intervention programs;(3) No record of visits to the Community Health Center (CHC) in the past 6 months.(4) Suffering from severe cognitive impairment or other psychiatric disorders affecting communication, rendering them unable to complete effective dialogues and questionnaires, either independently or with assistance.

Design outcomes

Primary

MeasureTime frame
Perceived Quality of Doctor-Patient Communication (Patient-Reported);

Secondary

MeasureTime frame
Patient‘s capability, motivation, and opportunity for self-management;Perceived Quality of Doctor-Patient Communication (Physician-Reported);Patient‘s Behavioral Adherence;Objective Physiological Indicators;

Countries

China

Contacts

Public ContactZhang Yuhang; Wu Chuanan

Tsinghua University, Shenzhen Longhua District People's Hospital

sitongluo@tsinghua.edu.cn+86 62791154

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026